CN Patent

CN102317293A — Raf抑制剂及其用途

Assigned to Arqule Inc · Expires 2012-01-11 · 14y expired

What this patent protects

本发明提供咪唑并 唑和咪唑并噻唑化合物以及它们的合成。本发明的化合物能够抑制RAF激酶(例如B-RAF V600E )的活性。所述化合物对细胞增殖性病症(例如癌症)的治疗有用。

USPTO Abstract

本发明提供咪唑并 唑和咪唑并噻唑化合物以及它们的合成。本发明的化合物能够抑制RAF激酶(例如B-RAF V600E )的活性。所述化合物对细胞增殖性病症(例如癌症)的治疗有用。

Drugs covered by this patent

Patent Metadata

Patent number
CN102317293A
Jurisdiction
CN
Classification
—
Expires
2012-01-11
Drug substance claim
No
Drug product claim
No
Assignee
Arqule Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.